These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 797498)

  • 1. Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications.
    Klotz U
    Clin Pharmacokinet; 1976; 1(3):204-18. PubMed ID: 797498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions and clinical pharmacokinetics.
    Kristensen MB
    Clin Pharmacokinet; 1976; 1(5):351-72. PubMed ID: 797504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics in the elderly.
    Crooks J; O'Malley K; Stevenson IH
    Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of anticonvulsants.
    Hvidberg EF; Dam M
    Clin Pharmacokinet; 1976; 1(3):161-88. PubMed ID: 797496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
    Keller F; Maiga M; Neumayer HH; Lode H; Distler A
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):275-82. PubMed ID: 6519129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of changes in drug elimination in children.
    Prandota J
    Dev Pharmacol Ther; 1985; 8(5):311-28. PubMed ID: 3899553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug disposition during the perinatal period.
    Heimann G
    Int J Biol Res Pregnancy; 1981; 2(1):1-14. PubMed ID: 7341492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic implications for the clinical use of propofol.
    Kanto J; Gepts E
    Clin Pharmacokinet; 1989 Nov; 17(5):308-26. PubMed ID: 2684471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of free drug monitoring.
    Dasgupta A
    Clin Chem Lab Med; 2002 Oct; 40(10):986-93. PubMed ID: 12476936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug prescribing in hepatobiliary disease.
    Roberts RK; Desmond PV; Schenker S
    Drugs; 1979 Mar; 17(3):198-212. PubMed ID: 378647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of commonly used age-based weight estimates for paediatric drug dosing in relation to the pharmacokinetic properties of resuscitation drugs.
    Carasco CF; Fletcher P; Maconochie I
    Br J Clin Pharmacol; 2016 May; 81(5):849-56. PubMed ID: 26714256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant therapy in aged patients. Clinical pharmacokinetic considerations.
    Bernus I; Dickinson RG; Hooper WD; Eadie MJ
    Drugs Aging; 1997 Apr; 10(4):278-89. PubMed ID: 9108988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
    Klotz U; Avant GR; Hoyumpa A; Schenker S; Wilkinson GR
    J Clin Invest; 1975 Feb; 55(2):347-59. PubMed ID: 1127104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The one-point method in predicting dosage regimen in case of hepatic and/or renal failure in presence or absence of change in volume of distribution.
    Ritschel WA; Thompson GA
    J Clin Pharmacol; 1979 Jul; 19(7):350-6. PubMed ID: 479379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein binding and kinetics of drugs in liver diseases.
    Blaschke TF
    Clin Pharmacokinet; 1977; 2(1):32-44. PubMed ID: 322909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-induced modifications of drug pharmacokinetics.
    Barre J; Houin G; Brunner F; Bree F; Tillement JP
    Int J Clin Pharmacol Res; 1983; 3(4):215-26. PubMed ID: 6381335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal disease and drug metabolism: an overview.
    Gibson TP
    Am J Kidney Dis; 1986 Jul; 8(1):7-17. PubMed ID: 3524205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.